4//SEC Filing
Szyman Catherine M. 4
Accession 0001225208-24-005882
CIK 0001099800other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 7:36 PM ET
Size
6.6 KB
Accession
0001225208-24-005882
Insider Transaction Report
Form 4
Szyman Catherine M
CVP, Critical Care & Vascular
Transactions
- Tax Payment
Common Stock
2024-05-07$85.09/sh−609$51,820→ 76,992.437 total - Award
Common Stock
2024-05-07+32,025→ 77,601.437 total
Footnotes (1)
- [F1]These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001438538
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 7:36 PM ET
- Size
- 6.6 KB